查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596185

監管事務市場：按服務、按適應症、按階段、按類別、按服務供應商、按公司規模、按最終用戶 - 2025-2030 年全球預測

Regulatory Affairs Market by Services, Indication, Stage, Category, Service Provider, Company Size, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年監管事務市場價值為156.3億美元，預計到2024年將達到172.2億美元，複合年成長率為10.63%，預計到2030年將達到317.1億美元。

市場研究領域的監管事務範圍包括遵守保護公眾健康和安全的法律法規、監督產品生命週期管理，醫療設備包括核准和註冊便利。監管事務的需要是保護公共利益、降低風險、維護市場進入，同時提高企業信譽。該領域的應用範圍從產品開發早期階段的策略建議到上市後監督和監管提交。最終用途範圍涵蓋產品功效、安全性和合規性領域。關鍵的成長要素包括不斷變化的監管環境、不斷增加的產品複雜性以及促進跨境市場滲透的全球化。數位化的快速進步為自動化和人工智慧簡化監管流程鋪平了道路，為公司提供了縮短上市時間、同時提高合規準確性的新機會。然而，這些進步也帶來了挑戰，例如需要跟上不斷變化的全球法規以及滿足不同合規要求相關的高成本。為了保持競爭力，公司必須在收集和分析監管資料、採用預測分析和利用數位轉型方面進行創新。公司應透過投資提高資料透明度的技術、與相關人員建立積極的合作夥伴關係以及採用敏捷的監管提交方法來抓住潛在的機會。我們還可以透過專注於建立強大的系統來促進創新，這些系統提供即時監管資訊和見解，徹底改變風險評估和決策流程。儘管取得了這些進展，但特定市場的複雜性和持續的監管變化構成了瓶頸，需要積極適應和提高技能。了解這些市場動態需要對政策趨勢保持敏感，有效回應監管要求，並加快策略回應以確保競爭力。

主要市場統計
基準年[2023] 156.3億美元
預測年份 [2024] 172.2億美元
預測年份 [2030] 317.1億美元
複合年成長率（%） 10.63%

市場動態：揭示快速發展的監管事務市場的關鍵市場洞察

供需的動態交互作用正在改變監管事務市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球藥物發現與開發顯著成長
    • 醫療保健產業政府法規的變化
    • 罕見疾病增加和新感染疾病出現
  • 市場限制因素
    • 提供醫藥服務的成本高昂
  • 市場機會
    • 主要市場參與者大力投資開拓醫療保健設備
    • 消費者對生技藥品和學名藥的偏好日益成長
  • 市場挑戰
    • 嚴格的政府政策和與監管事務相關的政策規定

波特五力：駕馭監管事務市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解監理事務市場的外部影響

外部宏觀環境因素在塑造監管事務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解監理事務市場的競爭格局

監管事務市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣監理事務市場供應商績效評估

FPNV 定位矩陣是評估監理事務市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 規劃您在監理事務市場的成功之路

對於希望加強在全球市場的影響力的公司來說，監管事務市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球藥物發現與開發顯著成長
      • 醫療保健領域政府法規環境的變化
      • 罕見疾病增加和新感染疾病出現
    • 抑制因素
      • 提供監管服務的成本高昂
    • 機會
      • 主要市場參與者對醫療保健設備開發的巨額投資
      • 消費者對生物製藥和學名藥的偏好日益成長
    • 任務
      • 與監管事務相關的嚴格政府政策和法規
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 監理事務市場：依服務分類

  • 法律代表
  • 產品註冊及臨床試驗申請
  • 監理諮詢
  • 撰寫和發布規範文件

第7章 監管事務市場（依指標）

  • 心臟病學
  • 免疫學
  • 神經病學
  • 腫瘤學

第8章 監理事務市場：依階段

  • 臨床研究
  • 臨床前

第9章 監理事務市場：依類別

  • 生物製藥
    • 生物相似藥
    • 生物技術
  • 藥品
    • 非專利的
    • 創新者
  • 醫療設備
    • 診斷
    • 治療藥物

第10章服務供應商監管事務市場

  • 公司內部
  • 外包

第11章 按公司規模分類的監管事務市場

  • 大的
  • 中等的
  • 小的

第12章 監理事務市場：依最終用途分類

  • 生技公司
  • 醫療設備公司
  • 製藥公司

第13章美洲監理事務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第14章亞太監管事務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第15章 歐洲、中東和非洲監管事務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Asphalion, SL
  • Cambridge Regulatory Services
  • Charles River Laboratories, Inc.
  • Clinilabs Inc.
  • Educo Life Sciences Ltd
  • Exalon GmbH
  • Genpact Ltd.
  • ICON PLC
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Medpace Inc.
  • NDA Group AB
  • Pharmalex GMBH
  • Qvigilance
  • WuXi AppTec Co. Ltd.
Product Code: MRR-0D217D5AEA5B

The Regulatory Affairs Market was valued at USD 15.63 billion in 2023, expected to reach USD 17.22 billion in 2024, and is projected to grow at a CAGR of 10.63%, to USD 31.71 billion by 2030.

The scope of regulatory affairs within the market research domain involves ensuring compliance with laws and regulations to protect public health and safety, overseeing product lifecycle management, and facilitating approvals and registrations across various industries such as pharmaceuticals, biotechnology, medical devices, and food services. The necessity of regulatory affairs lies in its role in safeguarding public interests, reducing risks, and maintaining market access while bolstering company credibility. This discipline's applications range from strategic advice in early product development stages to post-market surveillance and regulatory submissions. End-use extends to sectors focused on product efficacy, safety, and standard adherence. Key growth influencers include evolving regulatory landscapes, increasing product complexity, and globalization encouraging cross-border market penetration. A surge in digitization has opened avenues for streamlining regulatory processes through automation and AI, presenting fresh opportunities for companies to reduce time-to-market while improving compliance accuracy. However, these developments also bring challenges such as dealing with constantly changing global regulations and the high costs associated with meeting diverse compliance requirements. Market players must innovate in collecting and analyzing regulatory data, adopting predictive analysis, and leveraging digital transformation to remain competitive. Companies should navigate potential opportunities by investing in technologies that enhance data transparency, engage in proactive stakeholder collaboration, and employ agile methodologies in regulatory submissions. Innovation can also be fostered by focusing on building robust systems that offer real-time regulatory intelligence and insights, which stand to revolutionize risk assessment and decision-making processes. Despite these strides, the market's inherent complexity and continuous regulatory amendments can create bottlenecks, demanding proactive adaptation and skills enhancement. Understanding these market dynamics requires a keen awareness of policy trends, leading to accelerated, strategic responses in meeting regulatory demands efficiently, securing a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 15.63 billion
Estimated Year [2024] USD 17.22 billion
Forecast Year [2030] USD 31.71 billion
CAGR (%) 10.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Regulatory Affairs Market

The Regulatory Affairs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant growth in drug discovery and development worldwide
    • Changing governmental regulatory landscapes for healthcare sector
    • Rising prevalence of rare disorders and emergence of novel infectious diseases
  • Market Restraints
    • High cost of delivering regulatory services
  • Market Opportunities
    • Massive investments by the key market players for development of healthcare equipment
    • Increasing consumer preference for biologics and generic drugs
  • Market Challenges
    • Stringent governmental policies and regulations associated with regulatory affairs

Porter's Five Forces: A Strategic Tool for Navigating the Regulatory Affairs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Regulatory Affairs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Regulatory Affairs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Regulatory Affairs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Regulatory Affairs Market

A detailed market share analysis in the Regulatory Affairs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Regulatory Affairs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Regulatory Affairs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Regulatory Affairs Market

A strategic analysis of the Regulatory Affairs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Regulatory Affairs Market, highlighting leading vendors and their innovative profiles. These include Asphalion, S.L., Cambridge Regulatory Services, Charles River Laboratories, Inc., Clinilabs Inc., Educo Life Sciences Ltd, Exalon GmbH, Genpact Ltd., ICON PLC, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Medpace Inc., NDA Group AB, Pharmalex GMBH, Qvigilance, and WuXi AppTec Co. Ltd..

Market Segmentation & Coverage

This research report categorizes the Regulatory Affairs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Legal Representation, Product Registration & Clinical Trial Applications, Regulatory Consulting, and Regulatory Writing & Publishing.
  • Based on Indication, market is studied across Cardiology, Immunology, Neurology, and Oncology.
  • Based on Stage, market is studied across Clinical Studies and Preclinical.
  • Based on Category, market is studied across Biologics, Drugs, and Medical Devices. The Biologics is further studied across Biosimilars and Biotech. The Drugs is further studied across Generics and Innovator. The Medical Devices is further studied across Diagnostics and Therapeutics.
  • Based on Service Provider, market is studied across In-House and Outsourced.
  • Based on Company Size, market is studied across Large, Medium, and Small.
  • Based on End-Use, market is studied across Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant growth in drug discovery and development worldwide
      • 5.1.1.2. Changing governmental regulatory landscapes for healthcare sector
      • 5.1.1.3. Rising prevalence of rare disorders and emergence of novel infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of delivering regulatory services
    • 5.1.3. Opportunities
      • 5.1.3.1. Massive investments by the key market players for development of healthcare equipment
      • 5.1.3.2. Increasing consumer preference for biologics and generic drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent governmental policies and regulations associated with regulatory affairs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Regulatory Affairs Market, by Services

  • 6.1. Introduction
  • 6.2. Legal Representation
  • 6.3. Product Registration & Clinical Trial Applications
  • 6.4. Regulatory Consulting
  • 6.5. Regulatory Writing & Publishing

7. Regulatory Affairs Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. Immunology
  • 7.4. Neurology
  • 7.5. Oncology

8. Regulatory Affairs Market, by Stage

  • 8.1. Introduction
  • 8.2. Clinical Studies
  • 8.3. Preclinical

9. Regulatory Affairs Market, by Category

  • 9.1. Introduction
  • 9.2. Biologics
    • 9.2.1. Biosimilars
    • 9.2.2. Biotech
  • 9.3. Drugs
    • 9.3.1. Generics
    • 9.3.2. Innovator
  • 9.4. Medical Devices
    • 9.4.1. Diagnostics
    • 9.4.2. Therapeutics

10. Regulatory Affairs Market, by Service Provider

  • 10.1. Introduction
  • 10.2. In-House
  • 10.3. Outsourced

11. Regulatory Affairs Market, by Company Size

  • 11.1. Introduction
  • 11.2. Large
  • 11.3. Medium
  • 11.4. Small

12. Regulatory Affairs Market, by End-Use

  • 12.1. Introduction
  • 12.2. Biotechnology Companies
  • 12.3. Medical Device Companies
  • 12.4. Pharmaceutical Companies

13. Americas Regulatory Affairs Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Regulatory Affairs Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Regulatory Affairs Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Asphalion, S.L.
  • 2. Cambridge Regulatory Services
  • 3. Charles River Laboratories, Inc.
  • 4. Clinilabs Inc.
  • 5. Educo Life Sciences Ltd
  • 6. Exalon GmbH
  • 7. Genpact Ltd.
  • 8. ICON PLC
  • 9. IQVIA Holdings Inc.
  • 10. Laboratory Corporation of America Holdings
  • 11. Medpace Inc.
  • 12. NDA Group AB
  • 13. Pharmalex GMBH
  • 14. Qvigilance
  • 15. WuXi AppTec Co. Ltd.

LIST OF FIGURES

  • FIGURE 1. REGULATORY AFFAIRS MARKET RESEARCH PROCESS
  • FIGURE 2. REGULATORY AFFAIRS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. REGULATORY AFFAIRS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. REGULATORY AFFAIRS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. REGULATORY AFFAIRS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. REGULATORY AFFAIRS MARKET DYNAMICS
  • TABLE 7. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY LEGAL REPRESENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY PRODUCT REGISTRATION & CLINICAL TRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY GENERICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY INNOVATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY LARGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY MEDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SMALL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 248. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 258. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 268. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 278. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 288. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 308. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 318. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 328. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 335. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 336. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 337. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 338. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 339. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 341. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 342. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 343. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 344. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 345. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 346. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 347. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 348. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 349. POLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 350. POLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 351. POLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 352. POLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 353. POLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 354. POLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 355. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 356. POLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 357. POLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 358. QATAR REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 359. QATAR REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 360. QATAR REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 361. QATAR REG